A citation-based method for searching scientific literature


List of co-cited articles
523 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
Patrick M Forde, Jamie E Chaft, Kellie N Smith, Valsamo Anagnostou, Tricia R Cottrell, Matthew D Hellmann, Marianna Zahurak, Stephen C Yang, David R Jones, Stephen Broderick,[...]. N Engl J Med 2018
685
45

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.
Peter Goldstraw, Kari Chansky, John Crowley, Ramon Rami-Porta, Hisao Asamura, Wilfried E E Eberhardt, Andrew G Nicholson, Patti Groome, Alan Mitchell, Vanessa Bolejack. J Thorac Oncol 2016
35

Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.
Jean-Pierre Pignon, Hélène Tribodet, Giorgio V Scagliotti, Jean-Yves Douillard, Frances A Shepherd, Richard J Stephens, Ariane Dunant, Valter Torri, Rafael Rosell, Lesley Seymour,[...]. J Clin Oncol 2008
34

Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint.
Matthew D Hellmann, Jamie E Chaft, William N William, Valerie Rusch, Katherine M W Pisters, Neda Kalhor, Apar Pataer, William D Travis, Stephen G Swisher, Mark G Kris. Lancet Oncol 2014
171
32

Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy.
Apar Pataer, Neda Kalhor, Arlene M Correa, Maria Gabriela Raso, Jeremy J Erasmus, Edward S Kim, Carmen Behrens, J Jack Lee, Jack A Roth, David J Stewart,[...]. J Thorac Oncol 2012
146
29

Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial.
Catherine A Shu, Justin F Gainor, Mark M Awad, Codruta Chiuzan, Claud M Grigg, Aliyah Pabani, Robert F Garofano, Mark B Stoopler, Simon K Cheng, Abby White,[...]. Lancet Oncol 2020
100
27

Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer.
Enriqueta Felip, Rafael Rosell, José Antonio Maestre, José Manuel Rodríguez-Paniagua, Teresa Morán, Julio Astudillo, Guillermo Alonso, José Manuel Borro, José Luis González-Larriba, Antonio Torres,[...]. J Clin Oncol 2010
196
26

Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial.
Mariano Provencio, Ernest Nadal, Amelia Insa, María Rosario García-Campelo, Joaquín Casal-Rubio, Manuel Dómine, Margarita Majem, Delvys Rodríguez-Abreu, Alex Martínez-Martí, Javier De Castro Carpeño,[...]. Lancet Oncol 2020
75
29

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
P E Postmus, K M Kerr, M Oudkerk, S Senan, D A Waller, J Vansteenkiste, C Escriu, S Peters. Ann Oncol 2017
604
20

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.
Kathy S Albain, R Suzanne Swann, Valerie W Rusch, Andrew T Turrisi, Frances A Shepherd, Colum Smith, Yuhchyau Chen, Robert B Livingston, Richard H Feins, David R Gandara,[...]. Lancet 2009
869
20

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
Scott J Antonia, Augusto Villegas, Davey Daniel, David Vicente, Shuji Murakami, Rina Hui, Takayasu Kurata, Alberto Chiappori, Ki H Lee, Maike de Wit,[...]. N Engl J Med 2018
19

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell,[...]. N Engl J Med 2018
19

IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy.
William D Travis, Sanja Dacic, Ignacio Wistuba, Lynette Sholl, Prasad Adusumilli, Lukas Bubendorf, Paul Bunn, Tina Cascone, Jamie Chaft, Gang Chen,[...]. J Thorac Oncol 2020
52
36

Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR-Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study.
Wen-Zhao Zhong, Ke-Neng Chen, Chun Chen, Chun-Dong Gu, Jun Wang, Xue-Ning Yang, Wei-Min Mao, Qun Wang, Gui-Bin Qiao, Ying Cheng,[...]. J Clin Oncol 2019
63
28

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study.
Wen-Zhao Zhong, Qun Wang, Wei-Min Mao, Song-Tao Xu, Lin Wu, Yi Shen, Yong-Yu Liu, Chun Chen, Ying Cheng, Lin Xu,[...]. Lancet Oncol 2018
228
17

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
17

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
Scott J Antonia, Augusto Villegas, Davey Daniel, David Vicente, Shuji Murakami, Rina Hui, Takashi Yokoi, Alberto Chiappori, Ki H Lee, Maike de Wit,[...]. N Engl J Med 2017
17

Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC.
Shugeng Gao, Ning Li, Shunyu Gao, Qi Xue, Jianming Ying, Shuhang Wang, Xiuli Tao, Jun Zhao, Yousheng Mao, Bing Wang,[...]. J Thorac Oncol 2020
69
24

Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer.
Matthew J Bott, Stephen C Yang, Bernard J Park, Prasad S Adusumilli, Valerie W Rusch, James M Isbell, Robert J Downey, Julie R Brahmer, Richard Battafarano, Errol Bush,[...]. J Thorac Cardiovasc Surg 2019
86
18

A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.
R Rosell, J Gómez-Codina, C Camps, J Maestre, J Padille, A Cantó, J L Mate, S Li, J Roig, A Olazábal. N Engl J Med 1994
970
15

Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer.
Gideon M Blumenthal, Paul A Bunn, Jamie E Chaft, Caroline E McCoach, Edith A Perez, Giorgio V Scagliotti, David P Carbone, Hugo J W L Aerts, Dara L Aisner, Jonas Bergh,[...]. J Thorac Oncol 2018
61
24

Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.
Rodrigo Arriagada, Bengt Bergman, Ariane Dunant, Thierry Le Chevalier, Jean-Pierre Pignon, Johan Vansteenkiste. N Engl J Med 2004
15

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
15

Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease.
Jing Liu, Stephen J Blake, Michelle C R Yong, Heidi Harjunpää, Shin Foong Ngiow, Kazuyoshi Takeda, Arabella Young, Jake S O'Donnell, Stacey Allen, Mark J Smyth,[...]. Cancer Discov 2016
286
15

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
15

Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.
Miklos Pless, Roger Stupp, Hans-Beat Ris, Rolf A Stahel, Walter Weder, Sandra Thierstein, Marie-Aline Gerard, Alexandros Xyrafas, Martin Früh, Richard Cathomas,[...]. Lancet 2015
163
14

Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.
Giorgio V Scagliotti, Ugo Pastorino, Johan F Vansteenkiste, Lorenzo Spaggiari, Francesco Facciolo, Tadeusz M Orlowski, Luigi Maiorino, Martin Hetzel, Monika Leschinger, Carla Visseren-Grul,[...]. J Clin Oncol 2012
144
14

A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.
J A Roth, F Fossella, R Komaki, M B Ryan, J B Putnam, J S Lee, H Dhingra, L De Caro, M Chasen, M McGavran. J Natl Cancer Inst 1994
852
13


Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers.
Jamie E Chaft, Valerie Rusch, Michelle S Ginsberg, Paul K Paik, David J Finley, Mark G Kris, Katharine A R Price, Christopher G Azzoli, Matthew G Fury, Gregory J Riely,[...]. J Thorac Oncol 2013
60
21

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial.
Karen Kelly, Nasser K Altorki, Wilfried E E Eberhardt, Mary E R O'Brien, David R Spigel, Lucio Crinò, Chun-Ming Tsai, Joo-Hang Kim, Eun Kyung Cho, Philip C Hoffman,[...]. J Clin Oncol 2015
219
13

Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.
Luis Paz-Ares, Alexander Luft, David Vicente, Ali Tafreshi, Mahmut Gümüş, Julien Mazières, Barbara Hermes, Filiz Çay Şenler, Tibor Csőszi, Andrea Fülöp,[...]. N Engl J Med 2018
13

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.
Jean-Yves Douillard, Rafael Rosell, Mario De Lena, Francesco Carpagnano, Rodryg Ramlau, Jose Luis Gonzáles-Larriba, Tomasz Grodzki, Jose Rodrigues Pereira, Alain Le Groumellec, Vito Lorusso,[...]. Lancet Oncol 2006
12

Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II Study.
Liwen Xiong, Rong Li, Jiayuan Sun, Yuqing Lou, Weiyan Zhang, Hao Bai, Huiming Wang, Jie Shen, Bo Jing, Chunlei Shi,[...]. Oncologist 2019
29
41

Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC).
T R Cottrell, E D Thompson, P M Forde, J E Stein, A S Duffield, V Anagnostou, N Rekhtman, R A Anders, J D Cuda, P B Illei,[...]. Ann Oncol 2018
111
12

Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer.
Alain Depierre, Bernard Milleron, Denis Moro-Sibilot, Sylvie Chevret, Elisabeth Quoix, Bernard Lebeau, Denis Braun, Jean-Luc Breton, Etienne Lemarié, Sylvie Gouva,[...]. J Clin Oncol 2002
432
12

Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer.
Michael Thomas, Christian Rübe, Petra Hoffknecht, Hans N Macha, Lutz Freitag, Albert Linder, Norman Willich, Michael Hamm, Gerhard W Sybrecht, Dieter Ukena,[...]. Lancet Oncol 2008
203
11

PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Suresh Senan, Anthony Brade, Lu-Hua Wang, Johan Vansteenkiste, Shaker Dakhil, Bonne Biesma, Maite Martinez Aguillo, Joachim Aerts, Ramaswamy Govindan, Belén Rubio-Viqueira,[...]. J Clin Oncol 2016
216
11

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.
Anne Aupérin, Cecile Le Péchoux, Estelle Rolland, Walter J Curran, Kiyoyuki Furuse, Pierre Fournel, Jose Belderbos, Gerald Clamon, Hakki Cuneyt Ulutin, Rebecca Paulus,[...]. J Clin Oncol 2010
11

Survival benefit of neoadjuvant chemotherapy in non-small cell lung cancer: an updated meta-analysis of 13 randomized control trials.
Wei-An Song, Nai-Kang Zhou, Wei Wang, Xiang-Yang Chu, Chao-Yang Liang, Xiao-Dong Tian, Jun-Tang Guo, Xi Liu, Yang Liu, Wei-Min Dai. J Thorac Oncol 2010
119
11

Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review.
David Gilligan, Marianne Nicolson, Ian Smith, Harry Groen, Otilia Dalesio, Peter Goldstraw, Matthew Hatton, Penelope Hopwood, Christian Manegold, Franz Schramel,[...]. Lancet 2007
204
11

Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data.
R Arriagada, A Auperin, S Burdett, J P Higgins, D H Johnson, T Le Chevalier, C Le Pechoux, M K B Parmar, J P Pignon, R L Souhami,[...]. Lancet 2010
382
11

Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma.
Yang Qu, Katsura Emoto, Takashi Eguchi, Rania G Aly, Hua Zheng, Jamie E Chaft, Kay See Tan, David R Jones, Mark G Kris, Prasad S Adusumilli,[...]. J Thorac Oncol 2019
28
39

Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial.
Daniel C Betticher, Shu-Fang Hsu Schmitz, Martin Tötsch, Eva Hansen, Christine Joss, Christian von Briel, Ralph A Schmid, Miklos Pless, James Habicht, Arnaud D Roth,[...]. J Clin Oncol 2003
296
11

Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment.
K Junker, M Thomas, K Schulmann, F Klinke, U Bosse, K M Müller. J Cancer Res Clin Oncol 1997
113
11

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
10

Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
Jan P van Meerbeeck, Gijs W P M Kramer, Paul E Y Van Schil, Catherine Legrand, Egbert F Smit, Franz Schramel, Vivianne C Tjan-Heijnen, Bonne Biesma, Channa Debruyne, Nico van Zandwijk,[...]. J Natl Cancer Inst 2007
441
10

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Hossein Borghaei, Luis Paz-Ares, Leora Horn, David R Spigel, Martin Steins, Neal E Ready, Laura Q Chow, Everett E Vokes, Enriqueta Felip, Esther Holgado,[...]. N Engl J Med 2015
10

Computed tomography RECIST assessment of histopathologic response and prediction of survival in patients with resectable non-small-cell lung cancer after neoadjuvant chemotherapy.
William N William, Apar Pataer, Neda Kalhor, Arlene M Correa, David C Rice, Ignacio I Wistuba, John Heymach, J Jack Lee, Edward S Kim, Reginald Munden,[...]. J Thorac Oncol 2013
58
17

Grading of tumor regression in non-small cell lung cancer : morphology and prognosis.
K Junker, K Langner, F Klinke, U Bosse, M Thomas. Chest 2001
102
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.